Haiyan Liu1. 1. From the Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania.
Abstract
CONTEXT: Immunohistochemistry is a valuable tool in routine breast pathology, used for both diagnostic and prognostic parameters. The diagnostic immunomarkers are the scope of this review. Most breast lesions can be diagnosed on routine hematoxylin-eosin sections; however, in several scenarios, such as morphologically equivocal cases or metastatic tumors of unknown primary, the appropriate application of immunohistochemistry adds true value in reaching an accurate diagnosis. OBJECTIVE: To evaluate the diagnostic utility of the most commonly studied immunomarkers in the field of breast pathology by review of the literature, using the database of indexed articles in PubMed (US National Library of Medicine, Bethesda, Maryland) from 1976 to 2013. DATA SOURCES: Literature review, and author's research data and personal practice experience. CONCLUSIONS: The appropriate use of immunohistochemistry by applying a panel of immunomarkers and using a standardized technical and interpretational method will complement the morphologic assessment and aid in the accurate classification of difficult breast lesions and the identification of metastasis from a breast primary.
CONTEXT: Immunohistochemistry is a valuable tool in routine breast pathology, used for both diagnostic and prognostic parameters. The diagnostic immunomarkers are the scope of this review. Most breast lesions can be diagnosed on routine hematoxylin-eosin sections; however, in several scenarios, such as morphologically equivocal cases or metastatic tumors of unknown primary, the appropriate application of immunohistochemistry adds true value in reaching an accurate diagnosis. OBJECTIVE: To evaluate the diagnostic utility of the most commonly studied immunomarkers in the field of breast pathology by review of the literature, using the database of indexed articles in PubMed (US National Library of Medicine, Bethesda, Maryland) from 1976 to 2013. DATA SOURCES: Literature review, and author's research data and personal practice experience. CONCLUSIONS: The appropriate use of immunohistochemistry by applying a panel of immunomarkers and using a standardized technical and interpretational method will complement the morphologic assessment and aid in the accurate classification of difficult breast lesions and the identification of metastasis from a breast primary.
Authors: Thomas P Ahern; Andrew H Beck; Bernard A Rosner; Ben Glass; Gretchen Frieling; Laura C Collins; Rulla M Tamimi Journal: J Clin Pathol Date: 2016-10-11 Impact factor: 3.411
Authors: Matthew J Sikora; Britta M Jacobsen; Kevin Levine; Jian Chen; Nancy E Davidson; Adrian V Lee; Caroline M Alexander; Steffi Oesterreich Journal: Breast Cancer Res Date: 2016-09-20 Impact factor: 6.466